Logo Medpro

CONTACT

Category: HEOR

The New EU Regulations on Health Technology Assessment: Reshaping of HTA

Health and tech

Health technology deals with all aspects of healthcare, from preventive programs (vaccination drives), and diagnostic tests, to the development of devices or parts of equipment, drugs, or any medical procedure. Health technology assessment (HTA) entails a systematic appraisal of the short- and long-term outcomes of healthcare technologies. HTA provides information on various aspects of the […]

ChatGPT in HEOR: A keen look at the future of the Healthcare Industry

shake hands

In November 2022, OpenAI, an artificial intelligence (AI) research and deployment company, announced the official launch of ChatGPT (generative pre-trained transformer). ChatGPT is a large language model from the GPT-3.5 series using chatbot with machine learning and AI. This model has been designed to conduct interactive chats and maintain the flow of discussion in a […]

HEOR for the Effective Management of Healthcare Spending

Doctor

Healthcare systems globally have introduced numerous reforms, development, and incentives to improve health facilities. Every year, a significant amount of money is spent on healthcare goods and services. However, a significant share of health spending is ineffective due to operational inefficiencies and inefficient patient management. As per a JAMA article published in 2019, “The estimated cost of waste […]

Privacy Policy

MedPro Clinical Research
Website: https://crmedpro-eu.com
Effective Date: 24th February 2026

  1. Introduction

MedPro Clinical Research (“MedPro”, “we”, “us”, or “our”) is committed to protecting and respecting your privacy.

This Privacy Policy explains how we collect, use, disclose, and protect personal data when you:

  • Visit our website
  • Contact us by email, phone, or online forms
  • Engage with us as a client, business partner, vendor, or research contact
  • Apply for employment
  • Interact with us in a professional or commercial context

This policy complies with:

  • EU General Data Protection Regulation (EU GDPR)
  • UK General Data Protection Regulation (UK GDPR)
  • UK Data Protection Act 2018
  • Privacy and Electronic Communications Regulations (PECR)
  • ISO/IEC 27001:2022 information security principles
  1. Data Controller

The data controller responsible for your personal data is:

MedPro Clinical Research
Website: https://crmedpro-eu.com
Postal Address: MedPro Clinical Research, 34A Rutland Road, Maidenhead, SL64HY

If you have any questions regarding this Privacy Policy or wish to exercise your rights, please contact us using the details above.

  1. Data Protection Principles

In accordance with Article 5 GDPR, we process personal data in line with the following principles:

  • Lawfulness, fairness, and transparency
  • Purpose limitation
  • Data minimisation
  • Accuracy
  • Storage limitation
  • Integrity and confidentiality
  • Accountability

These principles are embedded within our Information Security Management System (ISMS).

  1. Categories of Personal Data We Collect

Depending on your interaction with us, we may collect:

4.1 Identity & Contact Information

  • Full name
  • Business address
  • Email address
  • Telephone number
  • Job title and company details

4.2 Professional & Business Information

  • Educational background
  • Professional experience
  • CVs and employment history (for applicants)
  • Professional certifications

4.3 Technical & Website Data

  • IP address
  • Device type and browser information
  • Pages visited
  • Referring URLs
  • Cookie identifiers

(See our Cookies Policy for more information.)

4.4 Recruitment Data

If you apply for employment, we may collect:

  • CV/resume
  • Employment history
  • Educational transcripts
  • Reference information
  • Identification details (where required for legal compliance)

4.5 Special Category Data

We do not intentionally collect special category data (e.g., health, racial origin, political beliefs) via our website.

If such data is required in a recruitment or contractual context, it will only be processed:

  • With explicit consent, or
  • Where required under employment or legal obligations
  1. How We Collect Personal Data

We collect personal data:

  • Directly from you (forms, email, phone)
  • Through website interaction (cookies, analytics tools such as Google Analytics)
  • From professional platforms such as LinkedIn
  • From publicly available sources (e.g., corporate registries)
  • From business partners, subcontractors, or service providers
  1. Legal Basis for Processing

We process personal data under the following lawful bases:

6.1 Contractual Necessity (Article 6(1)(b))

  • To enter into or perform contracts
  • To provide requested services

6.2 Legitimate Interests (Article 6(1)(f))

  • Responding to inquiries
  • Business development
  • Marketing to existing professional contacts
  • Website security and fraud prevention
  • Improving our services

We conduct Legitimate Interest Assessments (LIA) where required.

6.3 Consent (Article 6(1)(a))

  • Email marketing to new contacts
  • Non-essential cookies
  • Advertising tracking

You may withdraw consent at any time.

6.4 Legal Obligation (Article 6(1)(c))

  • Compliance with regulatory, tax, and legal obligations
  • Record keeping
  1. How We Use Your Personal Data

We use your data to:

  • Provide and manage clinical research services
  • Communicate with clients and business partners
  • Manage recruitment processes
  • Send marketing communications (where permitted)
  • Improve website performance
  • Maintain IT and system security
  • Comply with legal and regulatory obligations

We will not process your data for purposes incompatible with the original purpose without informing you.

  1. Marketing Communications

We may send marketing communications where:

  • You have consented; or
  • We have an existing professional relationship and it is permitted under PECR.

You may opt out at any time via:

  • The unsubscribe link in emails
  • Contacting us directly
  1. Disclosure of Personal Data

We may share personal data with:

  • Consultants and professional advisers
  • IT and hosting providers
  • Marketing and analytics providers
  • Regulatory authorities (where required)
  • Legal advisers
  • Corporate transaction partners (in case of merger or acquisition)

All third parties are subject to confidentiality and data protection obligations under written agreements.

  1. International Transfers

As a clinical research organisation operating internationally, your data may be transferred outside the EEA or UK.

Where transfers occur, we implement appropriate safeguards, including:

  • EU Standard Contractual Clauses (SCCs)
  • UK International Data Transfer Agreements (IDTA)
  • Adequacy decisions
  • Contractual and technical safeguards
  1. Information Security (ISO 27001 Alignment)

MedPro Clinical Research implements appropriate technical and organisational measures including:

  • Role-based access controls
  • Multi-factor authentication
  • Encryption in transit (TLS/HTTPS)
  • Secure hosting infrastructure
  • Vendor risk assessments
  • Logging and monitoring
  • Incident response procedures
  • Regular security reviews
  • Data retention controls

We maintain documented information security policies as part of our ISMS framework.

  1. Data Retention

We retain personal data only as long as necessary:

  • General enquiries: up to 12 months after last contact
  • Marketing contacts: up to 24 months of inactivity
  • Recruitment data: typically 12 months unless consent for longer retention
  • Legal/financial records: up to 7 years (or as legally required)

Retention periods may vary where legal or contractual requirements apply.

  1. Your Rights

Under GDPR and UK GDPR, you have the right to:

  • Access your personal data
  • Rectify inaccurate data
  • Erase data (right to be forgotten)
  • Restrict processing
  • Object to processing
  • Data portability
  • Withdraw consent
  • Lodge a complaint with a supervisory authority

EU residents: Contact your local Data Protection Authority.
UK residents: Contact the Information Commissioner’s Office (ICO).

  1. Security Breaches

In the event of a personal data breach, we will:

  • Assess risk
  • Notify supervisory authorities where required
  • Notify affected individuals where legally required
  • Document the incident in accordance with Article 33 GDPR
  1. Third-Party Links

Our website may contain links to third-party websites. We are not responsible for their privacy practices.

  1. Changes to This Policy

We may update this Privacy Policy periodically. Updates will be published on this page with a revised effective date.

Terms of Service

MedPro Clinical Research
Website: https://crmedpro-eu.com
Effective Date: 24th February 2026

1. Introduction

These Terms of Service (“Terms”) govern your access to and use of the website operated by MedPro Clinical Research (“MedPro”, “we”, “us”, or “our”).

By accessing or using this website, you agree to be bound by these Terms. If you do not agree, you must discontinue use immediately.

We reserve the right to amend these Terms at any time. Updates will be posted on this page with a revised effective date. Continued use of the website constitutes acceptance of the updated Terms.

2. Purpose of the Website

This website provides:

  • Information about MedPro Clinical Research

  • Details about our clinical research and consulting services

  • Business and professional contact opportunities

  • Recruitment information

Nothing on this website constitutes medical advice, clinical advice, or regulatory advice unless expressly stated.

3. Eligibility

You must:

  • Be at least 18 years old

  • Use the website only for lawful purposes

  • Not use the website in any way that violates applicable laws or regulations

4. Intellectual Property Rights

All content on this website, including:

  • Text

  • Graphics

  • Logos

  • Service marks

  • Trademarks

  • Images

  • Software

  • Layout and design

is the property of MedPro Clinical Research or its licensors and is protected by copyright, trademark, and other intellectual property laws.

You may:

  • View content for personal or internal business purposes

  • Print or download extracts for non-commercial use

You may not:

  • Reproduce, distribute, modify, or commercially exploit content

  • Mirror or frame the website

  • Remove copyright or proprietary notices

No license or ownership rights are transferred to you.

5. Trademarks

All trademarks, logos, and brand elements displayed on this website are the property of MedPro Clinical Research or third parties.

Use of any trademark without prior written consent is strictly prohibited.

6. Acceptable Use

You agree not to:

  • Attempt unauthorised access to systems or data

  • Introduce malicious software (viruses, trojans, etc.)

  • Interfere with website functionality

  • Use automated systems (bots/scrapers) without permission

  • Upload unlawful, defamatory, or infringing content

We reserve the right to suspend or restrict access for violations.

7. Privacy and Data Protection

Your use of the website is also governed by our Privacy Policy and Cookies Policy.

We process personal data in accordance with:

  • EU GDPR

  • UK GDPR

  • Data Protection Act 2018

  • PECR

We implement appropriate technical and organisational security measures aligned with ISO/IEC 27001:2022 principles.

8. Submissions

If you submit information to us (including inquiries, feedback, or job applications):

  • You confirm that the information is accurate

  • You grant us the right to process that information for legitimate business purposes

  • You confirm you have the authority to share such information

Confidential information should not be submitted unless explicitly requested through secure channels.

9. Electronic Communications

By contacting us electronically, you consent to receive communications electronically.

We may communicate with you by:

  • Email

  • Website notices

  • Contractual documentation

Electronic communications satisfy any legal requirement for written communication where permitted by law.

10. Third-Party Links

Our website may contain links to third-party websites.

We:

  • Do not control third-party websites

  • Are not responsible for their content

  • Do not endorse third-party services unless explicitly stated

Use of third-party websites is at your own risk.

11. Disclaimer of Warranties

To the maximum extent permitted by law:

  • The website is provided on an “as is” and “as available” basis

  • We make no warranties regarding accuracy, completeness, or reliability

  • We do not guarantee uninterrupted or error-free operation

Nothing in these Terms excludes liability that cannot legally be excluded under applicable law.

12. Limitation of Liability

To the extent permitted by law, MedPro Clinical Research shall not be liable for:

  • Indirect or consequential losses

  • Loss of profits or business

  • Loss of data

  • Business interruption

Nothing in these Terms excludes liability for:

  • Death or personal injury caused by negligence

  • Fraud or fraudulent misrepresentation

  • Any liability that cannot legally be excluded under EU or UK law

13. Cybersecurity and System Integrity

In line with our information security obligations, including ISO/IEC 27001 principles, we:

  • Monitor systems for security threats

  • Maintain protective technical controls

  • Log and investigate suspicious activity

Unauthorised attempts to access or interfere with our systems may result in legal action.

14. Regulatory Compliance

As a clinical research organisation, we operate within applicable regulatory frameworks. Information on this website is provided for general informational purposes and does not replace formal contractual or regulatory documentation.

15. Governing Law

These Terms shall be governed by and interpreted in accordance with:

  • The laws of [Insert EU Member State or UK jurisdiction]

Any disputes shall be subject to the exclusive jurisdiction of the courts of that jurisdiction.

16. Copyright Infringement

If you believe content on this website infringes your intellectual property rights, please contact us with:

  • Your contact details

  • Description of the alleged infringement

  • Evidence of ownership

  • The exact URL of the material

We will investigate and take appropriate action in accordance with applicable intellectual property laws.

17. Changes to These Terms

We reserve the right to modify these Terms at any time. Updated versions will be published on this page with a revised effective date.

Continued use of the website constitutes acceptance of any changes.

Cookies Policy

MedPro Clinical Research
Website: https://crmedpro-eu.com
Effective Date: 24th February 2026

  1. Introduction

This Cookies Policy explains how MedPro Clinical Research (“MedPro”, “we”, “us”, or “our”) uses cookies and similar tracking technologies on our website.

This policy is designed to comply with:

  • The EU General Data Protection Regulation (Regulation (EU) 2016/679)
  • The UK General Data Protection Regulation
  • The Privacy and Electronic Communications Regulations (PECR)
  • Information security principles aligned with ISO/IEC 27001:2022

We are committed to ensuring transparency, lawful processing, and appropriate technical and organisational safeguards in relation to personal data collected through cookies.

  1. What Are Cookies?

Cookies are small text files stored on your device when you visit a website. They allow the website to:

  • Recognise your device
  • Store preferences
  • Ensure secure functionality
  • Measure performance
  • Support analytics and advertising activities

Cookies may be:

  • Session cookies (deleted when you close your browser)
  • Persistent cookies (stored for a defined period)
  • First-party cookies (set by us)
  • Third-party cookies (set by external providers)
  1. Legal Basis for Processing

Under GDPR and UK GDPR, we process cookie-related personal data based on:

3.1 Strictly Necessary Cookies

Legal Basis:

  • Article 6(1)(f) GDPR – Legitimate Interests
    (Ensuring secure and functional website operation)

Consent is not required for strictly necessary cookies.

3.2 Analytics, Advertising, and Social Media Cookies

Legal Basis:

  • Article 6(1)(a) GDPR – Consent

These cookies are only activated after you provide explicit consent through our cookie consent mechanism.

You may withdraw consent at any time.

  1. Types of Cookies We Use

4.1 Strictly Necessary Cookies

These cookies are essential for:

  • Secure website access
  • Session management
  • Load balancing
  • Security monitoring

Without these cookies, the website cannot function properly.

Retention: Session-based or limited duration.

4.2 Performance & Analytics Cookies

We use analytics tools such as Google Analytics to collect aggregated statistical information, including:

  • Number of visitors
  • Pages visited
  • Time spent on the website
  • Referral sources
  • Device and browser type

IP anonymisation is enabled where applicable.

These cookies are deployed only after user consent.

Retention: As defined by the provider (typically up to 26 months unless configured otherwise).

4.3 Functionality Cookies

These cookies remember user preferences such as:

  • Language settings
  • Region selection
  • Consent preferences

Retention: Persistent (limited duration).

4.4 Social Media Cookies

Our website includes social media sharing features from:

  • LinkedIn

If you interact with these plugins, the relevant platform may collect data about your visit.

We do not control how these third parties process your personal data. Please refer to their privacy policies.

These cookies are set only after consent.

4.5 Advertising & LinkedIn Tracking Technologies

We use tracking technologies provided by LinkedIn, including:

  • LinkedIn Insight Tag (pixel)
  • LinkedIn Conversions API

Purpose:

  • Measure campaign performance
  • Create custom audiences
  • Build lookalike audiences
  • Improve advertisement relevance

Categories of data processed may include:

  • Name
  • Email address
  • Business contact information
  • Website interaction data
  • Device identifiers

Some server-side tracking technologies may not be blocked by browser-based ad blockers.

These cookies and tracking tools are activated only after explicit consent.

You can manage advertising preferences via your LinkedIn account.

  1. International Data Transfers

Some of our third-party service providers (e.g., analytics and advertising partners) may process personal data outside the European Economic Area (EEA) or the United Kingdom.

Where such transfers occur, we ensure appropriate safeguards are implemented, including:

  • Standard Contractual Clauses (SCCs)
  • UK International Data Transfer Agreements (IDTA)
  • Adequacy decisions (where applicable)
  1. Information Security & ISO 27001 Alignment

In alignment with ISO/IEC 27001:2022 principles, MedPro Clinical Research implements:

  • Access control mechanisms
  • Data minimisation practices
  • Encryption in transit (HTTPS/TLS)
  • Regular vendor risk assessments
  • Logging and monitoring controls
  • Defined data retention schedules
  • Incident response procedures

Third-party providers are subject to due diligence and contractual safeguards.

  1. Managing Your Cookie Preferences

You have the right to:

  • Accept or reject non-essential cookies
  • Withdraw consent at any time
  • Request information about personal data processed
  • Request deletion where applicable

You may:

  • Use our cookie consent banner
  • Adjust your browser settings
  • Use third-party opt-out mechanisms

Please note: Blocking certain cookies may impact website functionality.

  1. Data Subject Rights

Under GDPR and UK GDPR, you have the right to:

  • Access your personal data
  • Rectify inaccurate data
  • Request erasure
  • Restrict processing
  • Object to processing
  • Data portability
  • Lodge a complaint with a supervisory authority

For EU residents: You may contact your local Data Protection Authority.
For UK residents: You may contact the Information Commissioner’s Office (ICO).

  1. Updates to This Policy

We may update this Cookies Policy periodically to reflect changes in legal requirements, technology, or business practices.

Any changes will be published on this page with an updated effective date.

Thank you for your interest in our Webinar.

Please update your information and we will send you the Webinar Link in your email

Haruyoshi Ogata

FOUNDER & ENGAGEMENT LEAD

Haruyoshi has had extensive experience working with key persons across pharmaceutical and medical device companies, publishers, editorial boards, international societies, and KOLs. With over 20 years of experience in business development and marketing across multiple industries, he has shared his expertise with many clients.

Haruyoshi has knowledge of publishing industries, business communication, and culture of Japan as well as the APAC region. As the manager of business development for a global publisher, he launched the science communication department. During this period, he conducted educational seminars for publication ethics and publication planning. He also has in-depth experiences as a branch manager in the publication industry of Australia for three years.

Haruyoshi has served as Director, Business Development, at one of the global medical communication agencies and has been involved in over 100 scientific publication projects and the launch of international journals. In addition, he has expertise in publication strategies, pub SOP, and policy developments.

Haruyoshi has been a part of the medical communications team (including medical writing) that aided pharmaceutical and medical device companies, which published work by Japanese clinical researches and studies in global journals. He has helped to publish several articles and supplements in journals.

K. G. Mathew Tharakan

VICE PRESIDENT - GOVERNMENT SOLUTIONS

Mathew has 30 years of experience in transportation operations and engineering management along with professional expertise in rail vehicle engineering at Southeastern Pennsylvania Transportation Authority (SEPTA). In 2016, he joined SEPTA’s business division as a Disadvantaged Business Enterprise Manager, overseeing the participation of minority and women-owned businesses in procurement and major construction contracts.

As part of a cost-saving strategy, Mathew was asked to set up a new material warranty department for SEPTA. He was additionally tasked with the rewriting of SOPs and policies for their supply chain division. For over three decades, he has occupied various Asian American leadership positions, particularly Indian American community leadership roles in Philadelphia and Bucks and Montgomery counties.

Mathew graduated from the 2013 Pennsylvania Political Leaders Fellowship Program (CPL), and has extensively travelled and researched the Pennsylvania political landscape. Nationally, he was involved in grassroot organizing, fundraising, faith-based initiatives, and President Obama’s Asian American affairs and White House community partnership program. Moreover, he has served as the president of Conference of Minority Transportation Officials, a national organization with 40 chapters across the United States that is committed to the diversity and progress of minorities in the transportation industry. He further co-chaired Mayor Kenney’s transportation and infrastructure transition committee and was appointed as a member of the mayor’s advisory commission on Asian American affairs in July 2016.

In 2018, Mathew was asked to serve on the Bucks county transportation commission to assist with the Middletown township’s traffic development program. He has an MBA in finance and a master’s in computer science from Philadelphia University. In addition, he has a bachelor’s degree in history and political science from Loyola College University, Madras, and a diploma in electrical technology from Kerala University.

At Bioviser, Mathew supports business development activities for government solutions with prime contractors for data analytics. He is presently working on his doctoral program in business administration with an emphasis in data analytics.

Roque Pereira

CHIEF FINANCIAL OFFICER (CFO)

Roque is a natural-born leader and has been successfully running a leading emergency and medical care practice for 27 years in Virginia, USA. Additionally, having earned his degree from Bombay Veterinary College in 1977, he has been actively practicing veterinary medicine for 44 years. Among his many achievements, Roque is a member of the DC Academy of Veterinary Medicine.

As a business owner, Roque has been safeguarding the vital assets of his company by reducing risks and accurately maintaining/closing books; operating an efficient and effective financial structure through planning, analysis, and remedial measures; strategizing in various ways to influence the future direction of his company; and stimulating and driving business growth initiatives such as improved company cost reduction, procurement, pricing execution, and other innovations adding value to the company. Additionally, he has been making decisions related to team recruitment and people management, patient records, and compliance to IRS and OSHA standards. Further, he has been regularly attending national and international conferences.

As the CFO at Bioviser, Roque is primarily responsible for providing financial leadership and aligning business and finance strategies to grow the business. When he is not working, Roque loves to garden, bike, visit national parks, and travel to other countries.

Details sent successfully!

We have sent you the downloadable pdf on your email address. Please check your inbox.

Details sent successfully!

We have received your details. We will get in touch with you.

Search

JOIN US

CONTACT

Thank you for your interest in joining our team

Please update your information and we will get in touch with you shortly

Thank you for your interest in our white paper.

Please update your information and we will send you the pdf in your email

Haruyoshi Ogata

FOUNDER & ENGAGEMENT LEAD

Haruyoshi has had extensive experience working with key persons across pharmaceutical and medical device companies, publishers, editorial boards, international societies, and KOLs. With over 20 years of experience in business development and marketing across multiple industries, he has shared his expertise with many clients.

Haruyoshi has knowledge of publishing industries, business communication, and culture of Japan as well as the APAC region. As the manager of business development for a global publisher, he launched the science communication department. During this period, he conducted educational seminars for publication ethics and publication planning. He also has in-depth experiences as a branch manager in the publication industry of Australia for three years.

Haruyoshi has served as Director, Business Development, at one of the global medical communication agencies and has been involved in over 100 scientific publication projects and the launch of international journals. In addition, he has expertise in publication strategies, pub SOP, and policy developments.

Haruyoshi has been a part of the medical communications team (including medical writing) that aided pharmaceutical and medical device companies, which published work by Japanese clinical researches and studies in global journals. He has helped to publish several articles and supplements in journals.

Emilie Mai Anderberg

BUSINESS DEVELOPMENT & GLOBAL PARTNERSHIPS

Emilie holds a Master’s in Global Health and brings international experience in public health, strategic advisory, and cross-sectoral collaboration. Her experience spans organizations like Medtronic and other leading health institutions, where she has successfully led transformative initiatives, designed evidence-based strategies, and built impactful partnerships that translate knowledge into action for policy and decision-making.

Having lived and worked between Delhi and Copenhagen, Emilie offers a unique perspective on translating global insights into solutions for the Nordic and European context. Her work spans designing locally tailored solutions that advance health equity, strengthen sustainable health systems, and improve care delivery. She is passionate about leveraging innovative and collaborative approaches to deliver impact and support growth.

Outside of work, Emilie loves culture, art, music, and dance, enjoys exploring new places and nature, and is currently learning Hindi. She is passionate about community engagement, having worked in Ecuador on reforesting parts of the Amazon rainforest and in Nicaragua coordinating a Solidarity Brigade to support the social and sustainable development of low-income communities – an experience that also strengthened her Spanish proficiency while navigating complex, intersectional challenges. Additionally, she has collaborated with refugees on book projects in partnership with the Red Cross, working to bring forward the voices of underserved communities. Based in Copenhagen, she’s always happy to connect.

Santhosh Sirupa

DIRECTOR - OPERATIONS

A pharmacist by qualification, Santhosh has a master’s degree in pharmaceutics from Cromwell College, UK. Also, he has an M.S. in general chemistry from MTSU, USA. At MTSU, he was awarded graduate assistantship for two years for achieving high GPAs. He has over 14 years of experience in managing operations and delivery systems in the clinical research and drug safety industry. He also has extensive experience in pharmacovigilance, data analysis, and clinical research. He has proven himself as a successful delivery manager with competent team management skills.

Over the last five years, Santhosh earned a reputation for providing scalable business operational solutions that meet demanding time constraints and exceed expectations. He has worked with numerous prestigious organizations such as Accenture, Novartis, Syneos Health (formerly known as InVentiv), and Cognizant Technology Solutions Pvt. Ltd. His expertise lies in streamlining quality operations and controlling and coordinating for the improvement of deliverables.

As an SME, Santhosh has sound knowledge of pharmacovigilance and regulatory activities. He is an experienced corporate global trainer who has trained over 150 associates in pharmacovigilance across the globe.

Santhosh has headed an independent quality control team at the portfolio level, has been responsible for multiple accounts, and has acted as a BQA (preparing for audits, facing client audits, conducting internal audits, and highlighting risks). He has been actively involved in determining, negotiating, and agreeing on in-house quality procedures, standards, and specifications as well as assessing customer requirements and ensuring that they are met. He has participated in important activities such as setting customer service standards, investigating and setting standards for quality, and ensuring that processes comply with standards at both national and international levels. He has closely worked with cross-functional teams to establish standards, systems and procedures, writing management and technical reports, and customer’s charters; to determine training needs; and to implement proposed CAPAs. He has acted as a catalyst for change and improvement in performance and quality.

Ivan Dsouza

FOUNDER & PROJECT DIRECTOR

Over the years, Ivan has built a solid multifunctional foundation in the healthcare industry, working at various leadership positions. He has lent his expertise to strategy, business and product offering expansion, team building, sales, delivery, client servicing, training and development, and recruitment.

With over 15 years of experience in business, Ivan has been a significant contributor to the growth of numerous businesses. He has consulted clients for clinical research solutions in India and has continued to grow such services in major markets like the US, EU, and Japan along with growing business regions such as China, Taiwan, South Korea, and India.

Ivan has built teams in these regions and extensively travelled to manage numerous customer relationships with budgets of millions of dollars. His strengths lie in customizing solutions; one of his greatest achievements was to design a customized business solution in pharmacovigilance with a novel partnering idea that won his company a deal of over $10M.

Beyond Bioviser, Ivan maintains an active presence in the industry ecosystem by being a member on numerous forums. He loves supporting and encouraging entrepreneurship. He also serves as a member of a few clinical research ventures’ advisory boards and helps accelerate their journey to commercial success. Despite several work commitments, Ivan loves to carve out time to share a wealth of knowledge with his industry peers and is a guest lecturer at various leading clinical research institutes. Additionally, he is a speaker at industry conferences on clinical research.